Patent Assignment
Reel/Frame 025154/0975
Assignment of Assignor's Interest
Recorded: 2010-10-18
Pages: 7
Assignors
NORONHA, GLENN
Executed: 2006-11-09
MAK, CHI CHING
Executed: 2006-10-31
CAO, JIANGUO
Executed: 2006-10-31
RENICK, JOEL
Executed: 2006-10-31
MCPHERSON, ANDREW
Executed: 2006-10-31
ZENG, BINQI
Executed: 2006-10-31
PATHAK, VED P.
Executed: 2006-11-13
LOHSE, DANIEL L.
Executed: 2006-11-16
HOOD, JOHN D.
Executed: 2006-11-02
SOLL, RICHARD M.
Executed: 2006-11-10
Assignee
TARGEGEN, INC.
9380 JUDICIAL DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 18, 2010
From: NORONHA, GLENN; MAK, CHI CHING; CAO, JIANGUO; RENICK, JOEL
To: TARGEGEN, INC.
Reel/Frame 025155/0016 →
Assignment of Assignor's Interest
Oct 18, 2010
From: HOOD, JOHN D.; NORONHA, GLENN
To: TARGEGEN, INC.
Reel/Frame 025155/0047 →
Corrective Assignment to Correct the State of Incorporation from a California Corporation to a Delaware Corporation for the Assignment Previously Recorded on Reel 025154 Frame 0975. Assignor(S) Hereby Confirms the State of Incorporation for Targegen, Inc. to Be a Delaware Corporation.
Oct 29, 2013
From: NORONHA, GLENN; MAK, CHI CHING; CAO, JIANGUO; RENICK, JOEL
To: TARGEGEN, INC.
Reel/Frame 031510/0268 →
Change of Name
May 25, 2017
From: IMPACT THERAPEUTICS, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 042586/0643 →
Assignment of Assignor's Interest
May 25, 2017
From: TARGEGEN, INC.
To: IMPACT THERAPEUTICS, INC.
Reel/Frame 042512/0179 →
Security Interest
Nov 30, 2017
From: IMPACT BIOMEDICINES, INC.
To: LIND SA, LLC, AS COLLATERAL AGENT
Reel/Frame 044572/0660 →
Release of Security Interest
Feb 12, 2018
From: LIND SA LLC, AS COLLATERAL AGENT
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 044904/0628 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 042512 Frame: 0179. Assignor(S) Hereby Confirms the Assignment .
Aug 21, 2019
From: TARGEGEN, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 050297/0562 →